A novel cancer vaccine composed of human-recombinant epidermal growth factor linked to a carrier protein: Report of a pilot clinical trial
Open Access
- 1 April 1998
- journal article
- clinical trial
- Published by Elsevier in Annals of Oncology
- Vol. 9 (4) , 431-435
- https://doi.org/10.1023/a:1008261031034
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Fetal Effects of Epidermal Growth Factor Deficiency Induced in Rats by Autoantibodies against Epidermal Growth FactorPediatric Research, 1995
- An Immunologic Approach to Induction of Epidermal Growth Factor Deficiency: Induction and Characterization of Autoantibodies to Epidermal Growth Factor in RatsPediatric Research, 1995
- Relationships among the Expression of Epidermal Growth Factor Receptor, Proliferating Cell Nuclear Antigen Labeling Index, and Lymph Node Metastasis in Gastric CancerOncology, 1995
- The epidermal growth factor receptor as a target for therapy in breast carcinomaBreast Cancer Research and Treatment, 1994
- Expression of epidermal growth factor receptor and survival in upper aerodigestive tract cancer.Journal of Clinical Oncology, 1993
- Growth factors and their receptors as determinants in the proliferation and metastasis of human prostate cancerCancer and Metastasis Reviews, 1993
- Phase I and Imaging Trial of Indium 111-Labeled Anti-Epidermal Growth Factor Receptor Monoclonal Antibody 225 in Patients With Squamous Cell Lung CarcinomaJNCI Journal of the National Cancer Institute, 1991
- Signal transduction by receptors with tyrosine kinase activityPublished by Elsevier ,1990
- Iodine-125-Labeled Anti-Epidermal Growth Factor Receptor-425 in the Treatment of Glioblastoma MultiformePublished by S. Karger AG ,1990
- Epidermal growth factor receptors in human breast cancerBreast Cancer Research and Treatment, 1984